Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Public ClinicalTrials.gov record NCT01034462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder
Study identification
- NCT ID
- NCT01034462
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 442 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2009 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Oct 25, 2013
2009 – 2011
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 055 | Dothan | Alabama | 36305 | — |
| Forest Investigative Site 065 | Highlands Ranch | Colorado | 80130 | — |
| Forest Investigative Site 057 | Boca Raton | Florida | 33431 | — |
| Forest Investigative Site 060 | Boca Raton | Florida | 33432 | — |
| Forest Investigative Site 064 | Gainesville | Florida | 32607 | — |
| Forest Investigative Site 053 | Ocala | Florida | 34471 | — |
| Forest Investigative Site 061 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 059 | Winter Park | Florida | 32789 | — |
| Forest Investigative Site 070 | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site 066 | Smyrna | Georgia | 30080 | — |
| Forest Investigative Site 072 | Chicago | Illinois | 60634 | — |
| Forest Investigative Site 050 | Oak Brook | Illinois | 60523 | — |
| Forest Investigative Site 063 | Indianapolis | Indiana | 46260 | — |
| Forest Investigative Site 071 | Prairie Village | Kansas | 66206 | — |
| Forest Investigative Site 052 | Shreveport | Louisiana | 71104 | — |
| Forest Investigative Site 051 | Brooklyn | New York | 11214 | — |
| Forest Investigative Site 056 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 067 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 058 | Salem | Oregon | 97301 | — |
| Forest Investigative Site 054 | Allentown | Pennsylvania | 18104 | — |
| Forest Investigative Site 062 | San Antonio | Texas | 78229 | — |
| Forest Investigative Site 068 | Virginia Beach | Virginia | 23452 | — |
| Forest Investigative Site 069 | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01034462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2013 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01034462 live on ClinicalTrials.gov.